广州白云山医药集团股份有限公司（H股代码：00874，A股代码：600332）于2025年12月1日披露11月股份变动月报。报告期为2025年11月，公告显示公司已发行H股219,900,000股与A股1,405,890,949股均保持不变，法定注册股本总额仍为人民币1,625,790,949元。
公告披露，本月无新增发行股份、购回或注销事宜，亦无涉及期权、可换股票据或其他股本权益的变动。截至2025年11月30日，公司H股与A股的数量及库存股份数目均未发生变化。公司确认所有相关发行及交易均符合香港联合交易所有限公司《上市规则》及法律法规的要求。该公告由董事程宁签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.